Clik here to view.
FDA Approves Epanova for Severe Hypertriglyceridemia
Originally posted on Syn-Org-Chemist: FDA Approves Epanova for Severe Hypertriglyceridemia. View originalFiled under: Uncategorized
View ArticleClik here to view.
Parasitic worms of pigs could provide new treatments of human diseases
Originally posted on lyranara.me: New treatments for inflammatory bowel disease, rheumatoid arthritis, multiple sclerosis, diabetes and autism could be on the horizon, after a global University of...
View ArticleClik here to view.
Researchers investigate stress as a potential cause of periodontal disease
Originally posted on lyranara.me: A section of a mast cell. The cytoplasm, in yellow, releases granules, in green, in response to inflammation. Credit: CNRI/Science Source We all know what contributes...
View ArticleClik here to view.
Scientists take totally tubular journey through brain cells
Originally posted on lyranara.me: NIH scientists watched the inside of brain cell tubes, called microtubules, get tagged by a protein called TAT. Tagging is a critical process in the health and...
View ArticleClik here to view.
The US Food and Drug Administration (FDA) has approved Bayer HealthCare’s...
GADOBUTROL gadolinium(III) 2,2′,2”-(10-((2R,3S)-1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetate Gadobutrol, SH-L-562, Gadovist,138071-82-6 The US Food and Drug...
View ArticleClik here to view.
Alternative solid-state forms of a potent antimalarial aminopyridine: X-ray...
Graphical abstract: Alternative solid-state forms of a potent antimalarial aminopyridine: X-ray crystallographic, thermal and solubility aspects Alternative solid-state forms of a potent...
View ArticleClik here to view.
Polymorphs and co-crystals of haloprogin: an antifungal agent
Haloprogin Haloprogin is a topical antifungal agent. Its structure does not contain any of the functional groups typically exploited in hydrogen bond based co-crystal design. On the other hand, its...
View ArticleClik here to view.
Parasitic worms of pigs could provide new treatments of human diseases
Originally posted on lyranara.me: New treatments for inflammatory bowel disease, rheumatoid arthritis, multiple sclerosis, diabetes and autism could be on the horizon, after a global University of...
View ArticleClik here to view.
Lung-MAP Launches: First Precision Medicine Trial From National Clinical...
Today, NCI and many collaborators launched a unique clinical trial for people with a form of lung cancer. The study, LungMAP, will match participants to one of several different investigational...
View ArticleClik here to view.
A new twist on neuro disease: Discovery could aid people with dystonia,...
Originally posted on lyranara.me: Twist and hold your neck to the left. Now down, and over to the right, until it hurts. Now imagine your neck – or arms or legs – randomly doing that on their own,...
View ArticleClik here to view.
Provectus Phase III Melanoma Trial Results Earlier Than Planned?
Rose Bengal disodium 4 ,5,6,7-Tetrachloro-2′,4′,5′,7′-tetraiodo-3-oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-3′,6′-diolate disodium salt cas 632-69-9 C20 H2 Cl4 I4 O5 . 2 Na, mw 1017.36, PH 10...
View ArticleClik here to view.
Pharma vies to unleash immune system power on cancer
New therapies enlist immune cells to attack tumour cells, or make them more effective © ShutterstockDrug firms are investing heavily in clinical trials and collaborations as they seek to capitalise on...
View ArticleClik here to view.
Selexipag Meets Primary Endpoint in Pivitol Phase III Griphon Outcome Study...
June 16, 2014 Actelion Ltd today announced the top-line results of the pivotal Phase III GRIPHON study in 1,156 patients with pulmonary arterial hypertension (PAH) with selexipag, the first selective...
View ArticleClik here to view.
The USFDA has approved Navidea Biopharmaceuticals’ Supplemental New Drug...
Technetium (99mTc) tilmanocept……………….CAS1262984-82-6 [99mTc]-DTPA-mannosyl-dextran Systematic (IUPAC) name Dextran 3-[(2-aminoethyl)thio]propyl...
View ArticleClik here to view.
Quest for the ring – Synthesis of Vaniprevir (old)
Originally posted on Developing the Process: I was trying to think of a very catchy title to get readers to visit my website and take a look at my latest posting, and I thought, gees, what if I could...
View ArticleClik here to view.
Critical Outcome Technologies receives orphan drug designation for COTI-2
N’-(5,6,7,8-Tetrahydroquinolin-8-ylidene)-4-(2-pyridyl)piperazine-1-carbothiohydrazide http://criticaloutcome.com/110819_COTI-2%20Fact%20Sheet.pdf http://www.slideshare.net/trevorheisler/about-coti2...
View ArticleClik here to view.
HMPC Q&A Documents on Herbal Medicinal Products published
Originally posted on DRUG REGULATORY AFFAIRS INTERNATIONAL: HMPC Q&A Documents on Herbal Medicinal Products published Current questions and answers about the framework for herbal medicinal...
View ArticleClik here to view.
BMS-791325, Beclabuvir In Phase 2 for Hepatitis C (HCV)
BMS-791325, Beclabuvir IN PHASE 2 for Hepatitis C (HCV) An NS5B inhibitor. BMS-791325 preferably is CAS 958002-33-0 958002-36-3 (as hydrochloride) C36 H45 N5 O5 S, 659.838...
View ArticleClik here to view.
Scientists reveal molecular ‘yin-yang’ of blood vessel growth
Originally posted on lyranara.me: Biologists at The Scripps Research Institute (TSRI) have discovered a crucial process that regulates the development of blood vessels. The finding could lead to new...
View ArticleClik here to view.
Progesterone could become tool versus brain cancer
Originally posted on lyranara.me: The hormone progesterone could become part of therapy against the most aggressive form of brain cancer. High concentrations of progesterone kill glioblastoma cells...
View Article